Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation
Abstract
VE-cadherin-mediated cell-cell junction weakening increases paracellular permeability in response to both angiogenic and inflammatory stimuli. Although Semaphorin 3A has emerged as one of the few known anti-angiogenic factors to exhibit pro-permeability activity, little is known about how it triggers vascular leakage. Here we report that Semaphorin 3A induced VE-cadherin serine phosphorylation and internalization, cell-cell junction destabilization, and loss of barrier integrity in brain endothelial cells. In addition, high-grade glioma-isolated tumour initiating cells were found to secrete Semaphorin 3A, which promoted brain endothelial monolayer permeability. From a mechanistic standpoint, Semaphorin 3A impinged upon the basal activity of the serine phosphatase PP2A and disrupted PP2A interaction with VE-cadherin, leading to cell-cell junction disorganization and increased permeability. Accordingly, both pharmacological inhibition and siRNA-based knockdown of PP2A mimicked Semaphorin 3A effects on VE-cadherin. Hence, local Semaphorin 3A production impacts on the PP2A/VE-cadherin equilibrium and contributes to elevated vascular permeability.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sema3A is an antiangiogenic factor acting independently of VEGF, but also increases vascular permeability by destabilizing VE-cadherin through NRP-1 and PlexinA1 receptors.
“Sema3A, a member of semaphorin protein family, is antiangiogenic factor acting independently of VEGF, but also increases vascular permeability by destabilizing VE-cadherin through NRP-1 and PlexinA1 receptors (349).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [349]
Cites
Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
Switzer, C. H., Cheng, R. Y. S., Vitek, T. M., Christensen, D. J., Wink, D. A., & Vitek, M. P. (2011) · Oncogene · doi:10.1038/onc.2010.622 · Cited by 171 · see citing works
Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer
Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
- Authors
- Le Guelte, A., Galan-Moya, E.-M., Dwyer, J., Treps, L., Kettler, G., Hebda, J. K., Dubois, S., Auffray, C., Chneiweiss, H., Bidere, N., & Gavard, J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Corresponding author
- Gavard, Julie
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2012-01-01
- Volume
- 125
- Issue
- Pt 17
- Pages
- 4137-46
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2149342065
- Cited by
- 80
- References
- 2
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 7 · 2015: 10 · 2014: 6 · 2013: 8 · 2012: 2
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- semaphorin 3A, protein phosphatase 2A, VE-cadherin, endothelial permeability, paracellular permeability, cell-cell contact, serine phosphorylation, glioma stem cells, brain endothelial cells, vascular leakage, angiogenesis
- MeSH terms
- Animals, Brain, Brain Neoplasms, Cell Membrane Permeability, Enzyme Activation, Glioma, Humans, Mice, Inbred C57BL, Neoplastic Stem Cells, src-Family Kinases, Semaphorin-3A, Endothelial Cells, Cell Line, Tumor, Mice, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review